Collaboration Agreements (Tables)

12 Months Ended

Dec. 31, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Schedule Of Collaboration Revenue

Revenue was as follows for the years ended December 31, 2021 and 2020:

	Year Ended December 31,
	2021		2020
Neurocrine Biosciences:
Recognition of the transaction price	$	3,715	$	26,810
Research and development services		6,452		5,356
Milestone payments		5,270		—
Pacira BioSciences:
Milestone payments		3,000		—
Total collaboration revenue	$	18,437	$	32,166